Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Clinical Trials
Clinical imaging solutions
Affiliated with the American College of Radiology® (ACR®), ACR Image Metrix™ is an imaging contract research organization (CRO) that improves the efficiency of drug and medical device development programs. ACR Image Metrix works with pharmaceutical, biotechnology and medical device companies to integrate appropriate imaging modalities into clinical trials. With its vast network of imaging core laboratories equipped with cutting-edge technology, ACR Image Metrix provides comprehensive imaging services throughout the drug and/or medical device development process. ACR Image Metrix is an industry leader in the application of imaging modalities as predictive and prognostic biomarkers in clinical trials.
Centralized cardiac safety
How to achieve improved science at a lower cost with the most stakeholder convenience.
Advancing clinical trials and improving quality through EDC
Internet-based clinical trial technology has aided the ability for sponsor companies to easily access their study data throughout the conduct of their trials. Although the industry has been slower than most to adopt technology, the benefits are clear and as a result, adoption is gaining momentum.
The emerging science of pharmacogenomics in drug development
Doubters of pharmacogenomics beware. Personalized medicine has become a household word. Its exposure has long surpassed the day of the scientific journal and has now been mentioned in mainstream magazines such as Time (2001) and Newsweek (2005) as well as numerous newscasts and talk shows.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.